Human health risk assessment for microbial pesticides in the EU: challenges and perspectives.

IF 5.3 2区 环境科学与生态学 Q1 ENVIRONMENTAL SCIENCES
Jimena Barrero-Canosa, Julia Ebeling, Elaine F Kenny, Philip Marx-Stoelting, Norman Paege, Sabrina Feustel, Daniela Morais Leme
{"title":"Human health risk assessment for microbial pesticides in the EU: challenges and perspectives.","authors":"Jimena Barrero-Canosa, Julia Ebeling, Elaine F Kenny, Philip Marx-Stoelting, Norman Paege, Sabrina Feustel, Daniela Morais Leme","doi":"10.1186/s12940-025-01196-1","DOIUrl":null,"url":null,"abstract":"<p><p>The risk assessment of microbial pesticides in the European Union (EU) is covered by a regulatory framework based on EU Regulation 1107/2009 and 546/2011 together with the data requirements in EU Regulation 283/2013 and 284/2013, Part B, respectively (all amended in 2022). Furthermore, several guidance documents specify the data requirements for the human health assessment. As in other regulatory contexts, the assessment of hazardous properties of a microbial plant protection product (PPP) can be based on in vivo data. In order to decrease the use of test animals, support high-throughput data generation with larger repetition, and to facilitate faster testing methods, New Approach Methodologies (NAMs) for this field need to be developed. Here we focus on the assessment of the potential pathogenicity/infectivity and the presence of transferable antimicrobial resistance (AMR) genes of a microorganism when utilised as the active substance (AS) in a PPP. For the purpose of risk assessment of microbial PPPs, NAMs developed in view of the Next Generation Risk Assessment (NGRA) for chemicals can be applied. However, major drawbacks in the ability to use existing NAMs in the risk assessment of microbial pesticides are the reliability of Adverse Outcome Pathway (AOP) generated data for humans and the practicability of in vitro methods to test living microorganisms. It must be emphasised that tests for risk assessment are only useful if the test interpretation is clearly defined. Without prior definition of the possible effects and their interpretation, including the possible outcome for risk assessment, the test has limited value, as the results may raise more questions than answers. Overall, the regulatory assessment of the human health effects of microbial pesticides used in PPP needs reliable and robust data. These data should ideally be presented by an applicant based on animal-free study setups together with thorough literature searches.</p>","PeriodicalId":11686,"journal":{"name":"Environmental Health","volume":"24 1","pages":"43"},"PeriodicalIF":5.3000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12220163/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental Health","FirstCategoryId":"93","ListUrlMain":"https://doi.org/10.1186/s12940-025-01196-1","RegionNum":2,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

The risk assessment of microbial pesticides in the European Union (EU) is covered by a regulatory framework based on EU Regulation 1107/2009 and 546/2011 together with the data requirements in EU Regulation 283/2013 and 284/2013, Part B, respectively (all amended in 2022). Furthermore, several guidance documents specify the data requirements for the human health assessment. As in other regulatory contexts, the assessment of hazardous properties of a microbial plant protection product (PPP) can be based on in vivo data. In order to decrease the use of test animals, support high-throughput data generation with larger repetition, and to facilitate faster testing methods, New Approach Methodologies (NAMs) for this field need to be developed. Here we focus on the assessment of the potential pathogenicity/infectivity and the presence of transferable antimicrobial resistance (AMR) genes of a microorganism when utilised as the active substance (AS) in a PPP. For the purpose of risk assessment of microbial PPPs, NAMs developed in view of the Next Generation Risk Assessment (NGRA) for chemicals can be applied. However, major drawbacks in the ability to use existing NAMs in the risk assessment of microbial pesticides are the reliability of Adverse Outcome Pathway (AOP) generated data for humans and the practicability of in vitro methods to test living microorganisms. It must be emphasised that tests for risk assessment are only useful if the test interpretation is clearly defined. Without prior definition of the possible effects and their interpretation, including the possible outcome for risk assessment, the test has limited value, as the results may raise more questions than answers. Overall, the regulatory assessment of the human health effects of microbial pesticides used in PPP needs reliable and robust data. These data should ideally be presented by an applicant based on animal-free study setups together with thorough literature searches.

欧盟微生物农药的人类健康风险评估:挑战和前景。
欧盟(EU)微生物农药的风险评估由基于欧盟法规1107/2009和546/2011的监管框架以及欧盟法规283/2013和284/2013 B部分的数据要求(均于2022年修订)涵盖。此外,若干指导文件规定了人体健康评估的数据要求。与其他监管环境一样,微生物植物保护产品(PPP)的危险特性评估可以基于体内数据。为了减少实验动物的使用,支持高通量数据生成和更大的重复,并促进更快的测试方法,需要开发该领域的新方法方法(NAMs)。在这里,我们重点评估了在PPP中作为活性物质(as)使用的微生物的潜在致病性/传染性和可转移抗微生物药物耐药性(AMR)基因的存在。为了评估微生物PPPs的风险,可以应用根据下一代风险评估(NGRA)为化学品制定的NAMs。然而,在微生物农药风险评估中使用现有NAMs的主要缺陷是不良后果途径(Adverse Outcome Pathway, AOP)为人类生成的数据的可靠性以及体外方法检测活微生物的实用性。必须强调的是,风险评估测试只有在测试解释得到明确界定的情况下才有用。如果没有事先定义可能的影响及其解释,包括风险评估的可能结果,该测试的价值有限,因为结果可能提出更多的问题而不是答案。总体而言,对PPP中使用的微生物农药对人类健康影响的监管评估需要可靠和稳健的数据。理想情况下,申请人应根据无动物研究设置和彻底的文献检索提供这些数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Environmental Health
Environmental Health 环境科学-公共卫生、环境卫生与职业卫生
CiteScore
10.10
自引率
1.70%
发文量
115
审稿时长
3.0 months
期刊介绍: Environmental Health publishes manuscripts on all aspects of environmental and occupational medicine and related studies in toxicology and epidemiology. Environmental Health is aimed at scientists and practitioners in all areas of environmental science where human health and well-being are involved, either directly or indirectly. Environmental Health is a public health journal serving the public health community and scientists working on matters of public health interest and importance pertaining to the environment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信